Huatai Securities: The U.S.-Iran conflict has led to a general rise in chemical product prices; if the situation stabilizes, the chemical industry outlook is expected to improve.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Golden Ten Data reported on April 13 that Huatai Securities pointed out that the situation between the US, Israel, and Iran has led to a general increase in chemical product prices. If the Middle East geopolitical situation stabilizes, China and the world may see a new round of restocking in chemical products, driving demand growth. On the supply side, since 2025, the industry's capital expenditure growth has significantly declined. This, combined with initiatives such as “anti-involution” and “dual carbon controls”, is expected to support supply-side adjustments and the phasing out of outdated production capacity. In addition, since 2024, regions including Europe, Japan, and South Korea have generally been in a phase of capacity withdrawal. Catalyzed by the current global energy supply crisis, the elimination of outdated overseas capacity is expected to accelerate. Driven by both supply and demand, domestic enterprises are likely to continue increasing their global market share by leveraging supply chain stability, ushering in a new prosperity cycle.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Critical Decision That Will Change Supply in NEAR: Annual Production to Drop by 1.6%! Here Are the Details
BitcoinSistemi•2026/11/04 08:03

Michael Saylor's Bitcoin Treasury Secures Nearly $1 Billion in Profit
UToday•2026/11/04 07:51

Why Is SpaceX Stock Price Down Today?
Coinpedia•2026/11/04 07:36
Strong demand for Wegovy oral tablets drives Novo Nordisk (NVO.US) Q3 revenue and profit to surpass expectations, with annual performance guidance raised again.
Novo Nordisk released its financial report for the first three quarters of 2026 on November 4.
智通财经•2026/11/04 07:26
Crypto prices
MoreBitcoin
BTC
$78,306.44
+2.21%
Ethereum
ETH
$2,311.83
+2.59%
Tether USDt
USDT
$0.9984
+0.03%
BNB
BNB
$702.05
+1.14%
XRP
XRP
$1.28
+1.90%
USDC
USDC
$0.9997
+0.01%
Solana
SOL
$93.22
+1.54%
TRON
TRX
$0.3218
+0.34%
Zcash
ZEC
$1,287.32
+13.76%
Hyperliquid
HYPE
$85.13
+1.82%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now